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Abstract
For the purpose of revealing whether the sensitivity of the erythropoiesis to actinomycin D
(AMD) differs among different animal species, and to see the acting site of AMD on erythroid cell
specialization stage, the author observed the hourly change of the blood cell counts and bone mar-
row cells after AMD administration to mice, rats and rabbits, and obtained the following results: 1.
The data indicated that the erythropoiesis of ra bbit is sensitive to AMD, as much as that of mice,
while the rat is resistant to AMD, and its erythropoiesis is not affected by the similar dose of AMD
as in the case of mouse and rabbit. 2. The morphologic observations on the eradication process
of erythroblasts in the bone marrow of mice and rabbits indicates that AMD acts as to inhibit the
transformation of the stem cell to the proerythroblast but not on the erythroblast in the course of
specialization. The time required for the eradication coincided with the time of the proerythroblast
to the mature red cell. 3. Discussion has been made on the possibility of the common stem cell
to erythroid and granulocytic cells in relation to the lymphoid cells in bone marrow and their blast
form.
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In an adult organism, the cell populations constituting each organ
are controlled to stay at a certain level. This means that the cell prolifer-
ation and the cell loss are balanced in close relation with the function of
each organ. Thus, the red cell number in the circulating blood is cont-
rolled corresponding to the oxygenation level of hemoglobin (2, 26). Butfor the control of cell population itself, the erythropoietin is directly
responsible (1, 2, 18). Erythropoietin is believed to trigger the transforma.
tion of the stem cell to proerythroblast acting as the inducer for messenger
RNA (3, 4, 5), though some other activities in connection with the promo.
tion of specialization process of erythroblast are still in dispute (6, 8). No
control mechanism, however, is so far observed in the differentiation
process of erythroblasts after the induction (17). That is, in the stageslater than proerythroblast the specialization process of erythroblast seems
to proceed automatically with the repeated cell divisions, which is destined
ultimately to reach red cell by denucleation. This might be achieved by
the stable messenger RNA for hemoglobin, which is produced in the early
erythroid precursors (4, 7, 9).
It is known that actinomycin D (AMD), a colored antibiotics producedby Streptomyces species (10, 11), forms a tight but reversible complex with
DNA and blocks the synthesis of DNA-dependent RNA. For the complex
formation, guanine in DNA is believed to be the binding site of AMD.
This antibiotics has been widely used as the tool for the analysis of
messenger RNA synthesis and related phenomena. The messenger RNA
synthesis of erythroid cells has also been studied by using this antibiotics.But it has been shown that AMD totally eradicates the effect of erythro-
poietin as has been clearly demonstrated in vitro experiments (3,4). REISS-
MANN and associates also showed the selective eradication of erythropoiesis
in vivo by the injection of AMD into mice (12).
Using AMD, it became clear that the initial step of the differentia.
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tion, the change of stem cell to pronormoblast, includes the synthesis of
new messenger RNA rather than the activation of preexisting RNA temp.
lates (12, 13, 14). It should also be emphasized that the effect of the drug
was brought about at a level far below the lethal dose (15, 19)
The present experiment was undertaken to observe firstly if the eradi.
cation of erythropoiesis by AMD is seen generally among different animal
species other than mice and then if the acting site of AMD is limited only
to stem cell or to all the erythroblasts under specialization.
MATERIALS AND METHODS
Adult male animals, ddN mice weighing about 20 g, Wistar rats about 100 g,
and white rabbits about 2 kg were used. Mice and rats were injected AMD
without pretreatment but rabbits were divided into two groups, one receiving
pretreatment of phenylhydrazine injections and the other without pretreatment.
Controls were left without any treatment, though the anemic control of rabbits
received phenylhydrazine injection. Phenylhydrazine was injected subcutane.
ously in 2.5 % neutralized solution, 1 mljkg successively for 3 days. AMD was
dissolved in distilled water in three different concentrations, 5 .ugjmlfor rats,
2 .ug/ml for mice and 25 .ugjml for rabbits. They were kept in freezer at -20°C
and used within 10 days after preparation. In all the animals, AMD solution
was introduced subcutaneously. Number of circulating blood cells, i. e. red
blood cells (RBC), reticulocytes (RC), and white blood cells (WBC), were counted
with the blood from orbital plexus in mice and rats, and from ear vein in rabbits
by employing Toa Microcellcounter. On the termination of the experiment
bone marrow was obtained from the femur of each animal and cells were
observed on smeared samples after May-Griinwald-Giemsa stain. AMD used in
this experiment was kindly supplied by Japan Merck-Banyu Co., Ltd.
RESULTS
In the four ddN mice, receiving the administration of AMD, 60 ,ng/kg
daily for 6 days, the number percent of RC in the peripheral blood fell
below 10 %0 in two of them and 0 % in the rest (Table 1A). In the nine
mice receiving the injection of AMD, 120 /l.g/kg every other day for 6
days, all the animals showed 0 % RC, reconfirming Reissmann's result
(Table 1). In both series of experiments RBC count showed little change
before and after the AMD treatment indicating no destructive effect on
mature RBC. A slight decreasing tendency was observed in both hemo-
globin (Hb) and hematocrit (Ht) values, but mean corpuscular hemoglobin
remained almost unchanged (Tabe I).
Bone marrow films from the animals treated with AMD injection, 60
2
Acta Medica Okayama, Vol. 23 [1969], Iss. 3, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol23/iss3/1
Suppression of Erythropoiesis 167
Table 1. Blood counts of mice before and after the treatment with actinomycin D (AMD)
injection. (A) mean values from 4 mice treated with daily injection of AMD, 60 fLg/kg
for 6 days, and (B) mean from 9 mice treated with AMD, 120fLg/kg every
other day for 6 days and 360tLg/kg as total. RBC, RC, WBC, Hb
and Ht; see text, MCH; mean corpuscular hemoglobin
Determination I RBC Hb Ht RC WBC MCH(1Q6/mm3) (g/dl) (%) (%0) (l03/mm3) (fLug)
(A) Before AMD 7.13±0.83 11.3±0.5 42±49 34±18 4.1±0.65 15.8administration
After AMD 6.54±1.15 9.7±2.6 36±8.6 7 8.3±1.3 14.9administration
Before AMD 6.54±0.72 11.4±1.1 43±3.7 56±22 4.8±1.5 17.2(B) administration
After AMD 6.18± 1.05 9.4±1.2 35±4.6 0 6.7±2.5 15.2administration
ltg/kg daily for 6 days, showed a picture predominant in myeloid cells of
about 90 % with some lymphoid cells of about 10 %, and no erythroblasts
except one case which retained some erythroblasts of about 10 %.
In the animals receiving 120 l..tg/AMD/kg every other day for 6 days
also showed the similar change: no erythroblasts in the bone marrow with
predominant myeloid cells of 90 to 99 96 and some lymphoid cells of 1 to
10 % except one case in which the lymphoid cells predominated in the
bone marrow: 80.7% lymphoid cells and 19.2 % myeloid cells (Table 2).
Table 2. Individual effects of AMD on the myelogram of 13 mice appearing in
Table 1. (A); 360 fLg/kg in 6 divided doses for 6 days, (B); 360fLg/kg in
3 divided doses, every other day for 6 days, (C); mean of 6 controls
Animals I
(A) (B) (C)
I
El HI H2 H3 II Jl J2 Kl K2 Ll L2 MI M2 No
Total erythroid 0 10 0 0 0 0 1 0 0 0 0 0 0 21.0
Myeloid, young 35 23 36 40 42 41.5 29 34 9.6 58 16 29 18 26.8
mature neutrophils 53 54 54 53 53 48 62 57 9.6 41 80 77 78 36.2
eosinophils 1 2 2 1 0 0 0 0 0 0 0 0 0 3.8
basophils 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Lymphocytes 9 11 7 6 5 9 7 9 80.7 1 4 1 3 11.0
Plasma cells 0 0 1 0 0 0 0 0 0 0 0 0 0 0
Monocytes 2 0 0 0 0 0 0 0 0 0 0 0 0 0
Reticulum cells 0 0 0 0 0 1.5 1 0 0 0 0 0 0 0
To observe the process of eradication of erythroblasts in detail after
being exposed to AMD, 28 mice were injected with AMD, 120 ,,,.g/kg once
and couple of animals each were sacrificed successively every two hours
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up to 24 hours after the AMD injection. The remammg four animals
received the additional AMD injection, 120 pg/kg 24 hours after the first
injection, and these two couples were sacrificed at 48 and 72 hours after
the first AMD injection.
The hourly changes in erythroblast number in bone marrow are
shown in Fig. 1. As seen in the figure, the bone marrow before AMD
._.-=:~~
I '\. ~~.I~. ".
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,-;;~Ei·=:::::==::::,._.::=::::·_·~: ...·••• :············....
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Hours
Fig. I. Hourly changes in the number percent of erythroid cells in
mouse bone marrow after a single dose of actinomycin D, 120 /Lg/kg.
Curve I: the erythroblasts to all the nucleated cells in bone marrow.
Curve II: total number of the younger erythroblasts having basophilic
cytoplasm. Curve III: total number of early precursors. Curve IV:
number of the youngest precursors, proerythroblasts. Number percent of
erythroblast in individual groups, i. e. poly- and orthochromatic (poly
E+Orth E), late basophilic (Saso E II), early basophilic (Saso E I) and
proerythroblast (Pro E) are presented as the difference between two
curves; I-II; Poly E+OrthE, II-III; Baso E II, III-IV; Easo E I and
IV; Pro E
injection has as many erythroid cells as 21.0 % of all the nucleated cells.
They decreased to 5. 7 % in 24 hours after AMD administration, 4.0 %
after 48 hours and completely disappeared after 72 hours. Proerythrob1asts
disappeared first from the bone marrow and later the more mature ones
became predominant comprising larger part of the erythroid compartment
as the time proceeded.
Seven rats administered with AMD, 60/l g/kg daily or 120 p.g/kg every
other day for more than 4· weeks, also showed the decrease in RC number
in the circulating blood after one week of AMD administration but they
never disappeared. Differing from mouse, rats proved to be resistant to
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Table 3. Cell counts of circulating blood of Wistar rats treated with actinomycin
D injection, 120Jlg/kg every other day (A) and 60Jlg/kg every day (B)
for 29 days, data obtaiued on two representative cases
RBC, Hb, Ht, RC and WBC; see text
Day RBC Hb Ht RC WBC Weight(106/mm3) (g/d!) (%) (%0) (I03/mm3) (gm)
0 6.67 8.7 25 50 6.8 90
6 8.67 9.5 37 12 10.8(A)
19 8.49 11.0 41 37 12.2 90
29 8.22 10.4 41 62 13.1 136
0 6.10 7.4 33 29 8.9 92
6 6.81 7.0 32 3 10.3(B) 13 8.67 9.5 38 22 14.3
26 8.36 10.1 41 36 24.0 110
29 8.80 10.2 43 36 16.2 110
the drug. Unexpectedly, the RC recovered to the initial level gradually 3
to 4 weeks of AMD administration (Table 3). The change of the Price-Jones' curve, obtained on the photographed wet preparation from the
circulating erythrocytes, was very slight. Erythroblasts were 20 to 40 96
of all the nucleated cells in the bone marrow even after 20 to 30 days'
administration of AMD. Peripheral blood count, RBC, Hb, and Ht did
not decrease but they increased as the days proceeded, differing from
other animals (Table 3).
The effect of AMD was also observed in six rabbits. These animals
received AMD injection daily for 3 days, 100 p.g/kg/day for 3 animals,
50 l'.g/kg/day for two, and 25,u.gjkg/day for the remaining one. In the
cases receiving AMD 100 ,ag/kg daily, RC number in the circulating bloodbecame less than 1.0 96 4 days after the first administration of AMD, but
even in a dose of 25 and 50/-tg/kg, a marked decrease in RC number was
observed. No actual change coccurred in RBC number, Hb level and Ht
value before and after the AMD treatment in all the cases (Table 4).
Myelogram of the May-Grunwald-Giemsa stained smears proved that 3
days were sufficient to minimize the erythropoiesis in rabbit bone marrow(Table 5). The levels of erythroblast number were very low in the animals
receiving 50 /-tg/kg AMD daily for 3 days, and the granulocytic cells were
50 to 60 96 of all the nucleated cells. In the cases receiving 100 ,ug AMD/ kg
daily for 3 days, lymphoid cells were predominant in the bone marrow
nucleated cells, 9096 in one case and nearly 5096 in another one case, show-
ing an occasional severe suppression of granulop3iesis by the dose of 100 ,ag
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Table 4. Blood counts of rabbits before and after the treatment with actinomycin
D, daily subcutaneous injection for 3 days B: values before treatment
A: values after treatment
RBC, Hb, Ht, RC and WBC; see text
Animal TI T3 T4 T5 T6 T7
Actinomycin D I 100 50 25 100 100 50(fLg/kg/day) I
Weight
I
2.7 2.3 2.2 2.5 2.2 2.4(kg)
I B
A B A B A B A B A B A
RBC 5.62 4.35 4.08 4.98 5.30 5.23 5.01 5.68 6.03 5.68 6.03(106/mm3) . 5.10
Hb
I
10.5 12.8 9.8 9.7 10.2 10.7 10.2 9.5 11.0 11.5 11.0 11.0(g/dl)
Ht I 38 50 38 42 40 48 38 34 38 41 41 41(%) !
RC 43 0 31 8 28 4 18 21 0 10(%0)
WBC 3.6 7.8 4.3 11.0 7.8 10.1 6.2 15.4 7.2 11.5 7.6 12.1(l03/mm3)
AMDJkgjday (Table 5).
Then in the 9 anemic rabbits treated with phenylhydrazine injection,
the recovery of anemia was observed after treating with AMD, 50 p.g/kg/
day for 3 days, with one anemic control. Blood counts during 20 experi.
mental days of the representative rabbit are shown in Fig. 2. As seen in
RBC (XlO~ cu.mmJ
7
HH%) 3
:[ 2
I
30r
20" 1
IOl
oL 0
.//-~CjBC"j;J
'7/'Hb~ H~9~L(
__~=~_="~"'WiHt__-'Hb 10
"':---_-~-~Ht 8 29
6
4 10
RC 2
0!c-----':--:---:---,8~-:'::..::-~--:~q,.--~~2O. 0
1 P II t A~ 0 t Days
Fig. 2. Daily changes in blood counts of anemic rabbits treated with
phenylhydrazine followed by the administration of actinomycin D 50
fLg/kg/day for 3 days, solid lines; animal receiving actinomycin D in-
jections on the recovery stage of phenylhydrazine anemia, broken lines;
anemic control receiving only the phenylhydrazine injection. Data ob-
tained on one representative case RBC, Hb, Ht, RC; see text, PH;
phenylhydrazine injections, AMD; actinomycin D injections
6
Acta Medica Okayama, Vol. 23 [1969], Iss. 3, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol23/iss3/1
Suppression of Erythropoiesis 171
Table 5. Myelogram of the rabbits appearing in Table 4, animals treated
with actinomycin D for 3 successive days in various doses
without phenylhydrazine pretreatment
Animal TI T3 T4 T5 T6 T7 ControlDose (t-tg/kg) 100 50 25 100 100 50
ProE 1.4
B
..: Mk P
-= 0>-
... B 0.8 0.2 0.2 9.2w No P 0.2 1.4 0.8 0.4 13.8
0 1.4 1.0 3.2 2.4 1.0 19.4
Mitosis
Mybl 7.2 5.6 0.6 0.2 0.6 3.0
Pr 24.6 39.8 5.4 0.8 5.8 5.8
My 10.4 15.0 21.4 2.4 14.8 7.6
Mt 11.8 11.0 24.6 4.6 19.6 10.8
Nt I 5.2 3.8 1.2 2.6 7.4 6.6 7.8n 0.4 0.2 0.8 2.4 2.0 2.4
]I 0.2 2.0 1.4 1.0
IV 0.2 1.0 0.4
V 0.6 0.2
Pr 0.2 1.8 0.2
My 0.4 0.2
~ Eo Mt 1.0 0.6
~ Bd 0.8 0.6 0.4 1.0~
...:l Sg 0.2 1.0 0.1- 0.6 0.8 0.2
Pr I
Ba My
I
0.2 0.2 0.2 0.2Mt
R 0.2 0.2 0.4 0.2
Bl
\
0.2 0.4 0.2
Me Pr 3.2 1.4 0.2 0.8 0.8
Me 0.5 6.6 1.8 1.2 8.6 3.4
BI Ii 1.6 0.2 1.0 2.0 0.6Ly L 90.0 23.4 17.0 30.6 45.4 37.0 1.6S 13.8
Mitosis
I
-= Mgk
I
0.3 0.2 0.4 0.2 0.2~
PI I 0.6 0.6 0.6 0.2 1.6 0.6
Ret I 1.7 1.2 1.6 0.6
unidentified
I
0.2
the figure, during the first 4 days of AMD administration the recovery
rate of anemia showed no difference from the control except that RC
count became below 3 % in all the cases 4 days after the first injection of
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AMD and 0 % in the following 24 hours. At this stage red cell number
was at a lower level than that of anemic control. Hb nad Ht values
showed also slightly lower levels than control. RC stayed at 0 % for 2
days but they reappeared thereafter in the circulating blood, showing
a slight recovery of erythropoiesis by this time. In the bone marrow no
erythroblast was found 48 hours after the last AMD injection but after 72
hours proerythroblast reappeared (Fig. 3).
Figure 3. A proerythroblast which ap-
peared first in the rabbit bone marrow 72
hours after cessation of actinomycin D injec-
tion. 50 flg/kg daily for 3 days
DISCUSSION
From the observations on mouse hemopoietic tissue by several authors,
it has been elucidated that AMD selectively suppresses or eradicates the
erythroid cells from the bone marrow, but the present observations
revealed that sensitivity of erythroid cells to the drug varies considerably
depending on animal species. In sensitive animals like mouse and rabbit,
younger precursors of the erythroid cells in bone marrow were eradicated
selectively by injecting a small dose of AMD, but in resistant animals like
rat erythropoiesis was not so severely affected even with repeated admi.
nistration of AMD in a large dose. For example in mice, already 24 hours
after the single injection of the drug, 60 fl.g/kg, younger precursors were
hardly encountered on the bone marrow smear, while in rats nearly normal
hemopoiesis was observed even after 29 injections, 60 p.g/kg/day. Obser.
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vations proved that the eradication is achieved by the inhibition of the
transformation of the stem cell to proerythroblast with the maturation of
the erythroblast to red cell but not by the cell degeneration. It has also
been elucidated that the stem cell in itself is not affected by AMD because
proerythroblasts reappear at a certain period after cessation of the AMD
administration with complete recovery of erythropoiesis. Data are consis.
tent with those of REISSMANN and ITO (12) and of GURNEY and HOFSTRA
(16). The similar results wer~ obtained on anemic rabbit~ i.e. the activated
erythropoiesis by phenylhydrazine injection was suppressed by AMD:
erythroblast disappeared from the bone marrow after 3 injections of AMD
60 pg/kg/day. In this instance eradication of erythroid cells was attained
by the disappearance of younger precursors first and then the more mature
cells diminished, indicating inhibition of the transformation of the stem
cell to proerythroblast. The mechanism may suggest some congestive
hyperplasia of stem cells or of undifferentiated primitive cells in the bone
marrow. Actually, in the rabbits of phenylhydrazine anemia treated with
the injection of 50 p.g/kg AMD the bone marrow smears obtained 24 to 72
hours after the last AMD injection had anumber of "undifferentiated"
cells of large size with many granulocytic precursors. Morphologically,
they showed some pattern of young reticulum cells or blast form of
lymphocytes, though not clearly identified (Fig. 4), but the degree of
hyperplasia of undifferentiated cells was not so marked as would be ex·
pected. These undifferentiated cells were morphologically indentical with
the cells observed by T AKEBAYASHI in the marrow of the anemic rabbits
Fig. 4. Four" undifferentiated" cells which appeared in the rabbit bone marrow 24
hours after actinomycin D injection 50 flg/kg. The animal was preliminarily treated with
phenylhydrazine, and actinomycin D was injected at the recovery stage of anemia.
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receiving the excessive transfusion of red cells (17). Even under AMD
influence, the differentiated erythroblasts mature to red blood cells. This
differentiation is uncontrollable by any substances so far known.
In contrast to the erythroid cells, the granulocytic cells invariably
increased after AMD injection. The myelocytic differentiation was not
inhibited by the drug in dose used in this experiment. These facts seem
to suggest the possibility that the erythroid and granulocytic cells would
have the common stem cells, which is sometimes suggested by other
authors (20). Another important finding in this experiment is a marked
proliferation of lymphoid cells in the bone marrow, induced by the AMD
treatment, which rarely occurs in the hematopoietic marrow of untreated
animals. At present we have no direct evidence to show the relationship
between the blast form cells, lymphoid cells, granulocytes and erythroid
cells, but the data suggest that the lymphoid cells will have a cyclic change
with blast form cells (21) and they maybe transformed to erythroid or
granulocytic cells being affected by the specific inducers, which will be
erythropoietin for erythroid cells and some unknown substance for granu.
locytic cells.
Besides these, it is possible to calculate roughly the mean generation
time from the decreasing curve of erythroblasts in the marrow after AMD
administration. For example, for the complete disappearance of erythroid
cells from the bone marrow of mice, it took 72 hours. As the proerythro-
blasts mature to erythrocytes through 4 cell divisions and 4 steps of speci.
alization (22, 23, 24), the mitotic time at each step will be around 18
hours, though the generation time of the younger cells would be shorter
than those of more mature ones (25).
SUMMARY
For the purpose of revealing whether the sensitivity of the erythro.
poiesis to actinomycin D (AMD) differs among different animal species,
and to see the acting site of AMD on erythroid cell specialization stage,
the author observed the hourly change of the blood cell counts and bone
marrow cells after AMD administration to mice, rats and rabbits, and
obtained the following results:
1. The data indicated that the erythropoiesis of rabbit is sensitive to
AMD, as much as that of mice, while the rat is resistant to AMD, and
its erythropoiesis is not affected by the similar dose of AMD as in the case
of mouse and rabbit.
2. The morphologic observations on the eradication process of
10
Acta Medica Okayama, Vol. 23 [1969], Iss. 3, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol23/iss3/1
Suppression of Erythropoiesis. 175
erythroblasts in the bone marrow of mice and rabbits indicates that AMD
acts as to inhibit the transformation of the stem cell to the proerythro-
blast but not on the erythroblast in the course of specialization. The time
required for the eradication coincided with the time of the proerythroblast
to the mature red cell.
3. Discussion has been made on the possibility of the common stem
cell to erythroid and granulocytic cells in relation to the lymphoid cells in
bone marrow and their blast form.
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